Meribank Biotech Co., Ltd
4724
Rank in Stocks
#25372
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei... Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
Share Price
$0.27436013
Last synced: 2026-11-10
Market Cap
$26.33M
Change (1 day)
2.62%
Change (1 year)
-51.13%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Meribank Biotech Co., Ltd (4724)
Category
Healthcare
Operating Margin for Meribank Biotech Co., Ltd (4724)
Operating Margin as of November 2026 TTM: -25.87%
According to Meribank Biotech Co., Ltd's latest financial reports, its current operating margin (TTM) is -25.87%. At the end of 2025 the company had an operating margin of -11.19%.
Operating Margin history for Meribank Biotech Co., Ltd from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -25.87% | 131.19% |
| 2025 | -11.19% | -52.68% |
| 2024 | -23.65% | -55.00% |
| 2023 | -52.55% | -13.78% |
| 2022 | -60.95% | 2.23% |
| 2021 | -59.62% | 65.29% |
| 2020 | -36.07% | 1.12% |
| 2019 | -35.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -101.49% |
US
|
|
| -149.01% | -94.24% |
US
|
|
| 25.57% | -100.99% |
AU
|
|
| 31.23% | -101.21% |
BE
|
|
| 29.35% | -101.13% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Meribank Biotech Co., Ltd's operating margin
What is Meribank Biotech Co., Ltd's operating margin?
Meribank Biotech Co., Ltd's operating margin is -25.87%, as of Nov 2026.
What was Meribank Biotech Co., Ltd's operating margin in 2025?
In 2025, Meribank Biotech Co., Ltd's operating margin was -11.19%, compared with -23.65% in 2024.
How has Meribank Biotech Co., Ltd's operating margin changed since 2020?
From 2020 to 2025, Meribank Biotech Co., Ltd's operating margin was highest in 2025 (-11.19%) and lowest in 2022 (-60.95%).
How does Meribank Biotech Co., Ltd's operating margin compare with similar companies?
Meribank Biotech Co., Ltd's operating margin (-25.87%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.